Traditional infrared VNG / video goggles can represent a significant capital expense. SmartVertigo™ replaces that model with a one-time hardware cost and volume-indexed subscription tiers, scaled to your clinic’s throughput.
Tiers are designed to align cost with your actual patient volume — not punitive per-test fees. Final pricing will be published at FDA clearance.
SmartVertigo™ uses a smartphone you already own, replaces six-figure capital with a subscription, and scales across sites without rebuilding a vestibular lab in each one.
Market-context figures per the American Academy of Otolaryngology–Head and Neck Surgery Foundation, Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update), 2017. Illustrative of the wider market; not a claim about outcomes with SmartVertigo™.
Request a demo, ask a clinical question, or explore enterprise and federal licensing. Our team responds within one business day.